JDS Pharmaceuticals Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

JDS Pharmaceuticals General Information

Description

Provider of services in in the acquisition, development, and marketing of in-line and late-stage developmental pharmaceutical products. The company offers Pexeva for major depressive disorders, panic disorders, and obsessive compulsive disorders; and Lithobid for bipolar disorders. It identifies, develops, and delivers safe medicines.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 405 Lexington Avenue
  • The Chrysler Building, 59th Floor
  • New York, NY 10174
  • United States
+1 (212)
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Corporate Office
  • 405 Lexington Avenue
  • The Chrysler Building, 59th Floor
  • New York, NY 10174
  • United States
+1 (212)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

JDS Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore JDS Pharmaceuticals‘s full profile, request access.

Request a free trial

JDS Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore JDS Pharmaceuticals‘s full profile, request access.

Request a free trial

JDS Pharmaceuticals FAQs

  • When was JDS Pharmaceuticals founded?

    JDS Pharmaceuticals was founded in 2004.

  • Where is JDS Pharmaceuticals headquartered?

    JDS Pharmaceuticals is headquartered in New York, NY.

  • What industry is JDS Pharmaceuticals in?

    JDS Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is JDS Pharmaceuticals a private or public company?

    JDS Pharmaceuticals is a Private company.

  • What is the current valuation of JDS Pharmaceuticals?

    The current valuation of JDS Pharmaceuticals is .

  • What is JDS Pharmaceuticals’s current revenue?

    The current revenue for JDS Pharmaceuticals is .

  • How much funding has JDS Pharmaceuticals raised over time?

    JDS Pharmaceuticals has raised $62M.

  • Who are JDS Pharmaceuticals’s investors?

    Altaris and Galen Partners have invested in JDS Pharmaceuticals.

  • When was JDS Pharmaceuticals acquired?

    JDS Pharmaceuticals was acquired on 14-Aug-2007.

  • Who acquired JDS Pharmaceuticals?

    JDS Pharmaceuticals was acquired by Noven Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »